All funds

DNB Grønt Skifte Norden A

Equity fund

1 year

Globe

Europe

Largest region

Medium

Risk

Annual costs

Morningstar

 

Partial 

Sustainability

Development

Last 5 years
( ann.)

Description

  • DNB Grønt Skifte Norden investerer hovedsakelig i selskaper hjemmehørende i Norden; eller fra selskaper som utøver en betydelig del av virksomheten i Norden; eller i aksjer som hovedsakelig omsettes i Norden. Fondet søker å investere i selskaper som har en potensiell positiv påvirkning på miljøet. Syv grønne områder er i fokus: klimaendringer, vannforvaltning, energieffektivisering, avfallshåndtering, vann- og luftforurensning, avskoging og biomangfold. Fondets investeringer i fremmed valuta vil ikke sikres til norske kroner. Fondet er aktivt forvaltet og har som mål å over tid gi bedre avkastning etter kostnader enn fondets referanseindeks.
    Read more

Investment horizon

  • DNB Grønt Skifte Norden A is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.

Characteristics

  • Minimum amount
  • Sharpe 3 years
  • Price/NAV

    07 Sept 2025

  • Start date
    23 Nov 1989
  • ISIN
    NO0010102866

Risk

  • Medium (4 of 7)

Morningstar rating

  • The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.

Sustainability

Annual cost

  • Ongoing costs

    Includes management fees of 0,85 %

  • Platform fee
  • Kickback fee
  • Annual running costs

Other costs

  • Performance-based fee
  • Transaction costs

  • Costs for any currency exchanges are not included.

Allocation

  • Stocks 100%
    Interest 0%

Portfolio

Shows the fund's largest investments.

  • Novo Nordisk AS Class B
    7.2%
  • Nordea Bank Abp
    5.6%
  • Atlas Copco AB Class A
    5.2%
  • Nokia Oyj
    4.5%
  • DSV AS
    3.5%
  • Volvo AB Class B
    3.2%
  • Hexagon AB Class B
    3.1%
  • NKT AS
    3.0%
  • AstraZeneca PLC
    2.8%
  • Novonesis (Novozymes) B Class B
    2.8%